Oxygen therapy after stroke is one of the most researched applications of hyperbaric medicine, but the picture is more complicated than most clinics will tell you. HBOT shows real promise for chronic stroke recovery. Routine supplemental oxygen for acute stroke patients? The largest trials say it does not help.
Understanding the difference could save you thousands of dollars and help you focus on treatments that actually work.
- HBOT can improve neurological function even years after a stroke, according to Efrati’s 2013 randomized controlled trial
- The SO2S trial (8,003 patients) found that routine normobaric oxygen after acute stroke does not improve outcomes
- HBOT works by reactivating dormant neurons in the ischemic penumbra, the border zone around dead brain tissue
- Evidence is strongest for chronic stroke (months to years post-event), not the acute phase
- A typical HBOT stroke protocol involves 40-60 sessions at 1.5-2.0 ATA
Acute Stroke vs. Chronic Stroke: Why the Timing Matters
Stroke is the leading cause of long-term disability worldwide. After the initial event, many patients are left with permanent deficits: paralysis, speech difficulties, cognitive impairment. The brain damage comes from interrupted blood flow, which starves neurons of oxygen.
This is where things get confusing. It seems logical that giving more oxygen to an oxygen-starved brain would help. But oxygen therapy for stroke works very differently depending on when it is delivered.
Acute stroke (first 72 hours): During this window, the brain is in crisis. Blood flow is disrupted, inflammatory cascades are active, and the blood-brain barrier may be compromised. Adding supplemental oxygen during this phase has not been shown to help, and may cause harm in some contexts.
Chronic stroke (weeks to years after): This is where HBOT shines. Damaged but not dead neurons in the penumbra zone can potentially be reactivated with repeated hyperbaric sessions. The brain has stabilized enough to respond to regenerative stimulation.
The Efrati 2013 Study: A Turning Point
The most important HBOT-stroke study was published in 2013 by Dr. Shai Efrati and colleagues at Tel Aviv University. The randomized controlled trial enrolled stroke patients who were 6-36 months post-event and had persistent neurological deficits.
Patients received 40 sessions of HBOT at 2.0 ATA over two months. The results changed the conversation about late-stage stroke recovery.
Brain imaging showed significantly increased neuronal activity after the treatment period compared to control periods. Patients experienced improvements including:
- Reversal of paralysis in some patients
- Increased sensation in affected limbs
- Renewed ability to use language
- Improved daily functioning
“HBOT can lead to significant neurological improvements in post-stroke patients even at chronic late stages, challenging the assumption that brain damage after stroke is permanent.” – Efrati et al., PLoS ONE (2013)
The critical insight was that brain damage after stroke exists on a spectrum. Some neurons are dead and cannot be recovered. But others in the penumbra, the border zone surrounding the infarct, are metabolically dormant. They are alive but not functioning. HBOT appears to provide enough oxygen to reawaken these “sleeping” neurons. For more on how hyperbaric chambers help stroke patients, see our detailed guide.
The Penumbra Concept: Why HBOT Works for Chronic Stroke
The ischemic penumbra is the target tissue for HBOT after stroke. This region surrounds the core infarct (dead tissue) and contains neurons that are structurally intact but functionally impaired due to inadequate blood supply.
In the days after a stroke, the penumbra either recovers or converts to dead tissue. Standard acute stroke treatments (clot-busting drugs, thrombectomy) aim to save the penumbra by restoring blood flow quickly.
But even months or years later, some penumbral tissue persists in a dormant state. HBOT delivers enough dissolved oxygen to these regions to restart cellular metabolism, allowing dormant neurons to fire again.
Brain SPECT imaging in Efrati’s studies confirmed this mechanism. Areas of low metabolic activity before treatment showed increased activity after HBOT, and these changes correlated with clinical improvements.
Normobaric Oxygen for Acute Stroke: The Evidence Says No
The Stroke Oxygen Study (SO2S), published in JAMA in 2017, was the largest trial ever conducted on oxygen supplementation after acute stroke. It randomly assigned 8,003 patients within 24 hours of stroke onset to one of three groups:
- Continuous oxygen for 3 days
- Nocturnal oxygen only for 3 days
- No supplemental oxygen (control)
At 3 months, there was no significant difference in death or disability between the oxygen groups and the control group. The trial conclusively showed that routine low-dose supplemental oxygen does not improve outcomes after acute stroke.
This does not mean oxygen is useless for stroke patients. The SO2S trial tested normobaric oxygen at normal pressure, not HBOT. And it targeted the acute phase, not chronic recovery. The distinction is important: the failed acute trials do not invalidate the positive chronic HBOT research.
Evidence by Stroke Type
| Stroke Type | Oxygen Therapy | Evidence Level | Notes |
|---|---|---|---|
| Ischemic stroke (chronic) | HBOT | Moderate (RCTs) | Strongest evidence. Efrati 2013 trial is the landmark study |
| Ischemic stroke (acute) | Normobaric O2 | Strong negative | SO2S trial (n=8,003) showed no benefit |
| Ischemic stroke (acute) | HBOT | Limited | Small case reports show potential. Logistically challenging |
| Hemorrhagic stroke | HBOT | Very limited | Theoretical benefit, but few clinical studies exist |
| TIA (mini-stroke) | Any | No evidence | TIAs resolve without permanent damage. No role for O2 therapy |
What a Stroke HBOT Protocol Looks Like
Based on published research protocols:
- Pressure: 1.5-2.0 ATA (most studies use 2.0 ATA)
- Duration: 60-90 minutes per session
- Frequency: 5 sessions per week
- Total sessions: 40-60 (8-12 weeks of treatment)
- Oxygen: 100% via mask or hood inside a multiplace chamber
Some protocols use an intermittent approach: periods of breathing 100% oxygen alternating with brief “air breaks” of normal room air. This cycling between hyperoxia and normoxia may enhance the neuroplastic response.
Cost and Insurance
HBOT for stroke recovery is not FDA-approved, which means insurance will not cover it in most cases. Out-of-pocket costs are significant:
- Per session: $100-$300
- Full protocol (40-60 sessions): $4,000-$18,000
- Time commitment: 8-12 weeks of near-daily sessions
Some patients see improvement within the first 20 sessions. Others require the full course. A retrospective analysis of Efrati’s patients found that the degree of improvement correlated with the number of sessions completed.
When to Consider HBOT After Stroke
HBOT for stroke recovery may be worth exploring if:
- You are at least 3 months post-stroke with stable but persistent deficits
- Standard rehabilitation (physical therapy, occupational therapy, speech therapy) has plateaued
- Brain imaging shows viable penumbral tissue (not all dead tissue)
- You can commit to 40+ sessions over 2-3 months
- You can afford the out-of-pocket cost
HBOT should complement, not replace, conventional stroke rehabilitation. The best outcomes in studies came from patients who continued physical and occupational therapy alongside HBOT.
Sources
- Efrati S, et al. Hyperbaric oxygen induces late neuroplasticity in post stroke patients: randomized, prospective trial. PLoS ONE. 2013;8(1):e53716. doi:10.1371/journal.pone.0053716
- Roffe C, et al. Effect of routine low-dose oxygen supplementation on death and disability in adults with acute stroke: the Stroke Oxygen Study randomized clinical trial. JAMA. 2017;318(12):1125-1135. doi:10.1001/jama.2017.11463
- Hadanny A, et al. Hyperbaric oxygen therapy improves neurocognitive functions of post-stroke patients. Restor Neurol Neurosci. 2020;38(1):93-107. doi:10.3233/RNN-190959
- Boussi-Gross R, et al. Hyperbaric oxygen therapy can improve post concussion syndrome years after mild traumatic brain injury. PLoS ONE. 2013;8(11):e79995.
- Tal S, et al. Hyperbaric oxygen therapy after acute ischemic stroke with large penumbra: a case report. Egypt J Neurol Psychiatr Neurosurg. 2020;56:96. doi:10.1186/s41983-020-00225-9
Medical Disclaimer
The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Author
Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.
